Abstract:Immune therapeutic exosomes, derived exogenously from dendritic cells (DCs), the 'directors' of the immune response, are receiving favorable safety and tolerance profiles in phase I and II clinical trials for a growing number of inflammatory and neoplastic diseases. DC-derived exosomes (EXO), the focus of this review, can be custom tailored with immunoregulatory or immunostimulatory molecules for specific immune cell targeting. Moreover, the relative stability, small size and rapid uptake of EXO by recipient immune cells offer intriguing options for therapeutic purposes. This necessitates an in-depth understanding of mechanisms of EXO biogenesis, uptake and routing by recipient immune cells, as well as their in vivo biodistribution. Against this backdrop is recognition of endogenous exosomes, secreted by all cells, the molecular content of which is reflective of the metabolic state of these cells. In this regard, exosome biogenesis and secretion is regulated by cell stressors of chronic inflammation and tumorigenesis, including dysbiotic microbes, reactive oxygen species and DNA damage. Such cell stressors can promote premature senescence in young cells through the senescence associated secretory phenotype (SASP). Pathological exosomes of the SASP amplify inflammatory signaling in stressed cells in an autocrine fashion or promote inflammatory signaling to normal neighboring cells in paracrine, without the requirement of cell-to-cell contact. In summary, we review relevant lessons learned from the use of exogenous DC exosomes for immune therapy, as well as the pathogenic potential of endogenous DC exosomes.

Exosomes derived from programmed cell death: mechanism and biological significance

Programmed cell death: molecular mechanisms, biological functions, diseases, and therapeutic targets

Gene Expression Regulation and the Signal Transduction of Programmed Cell Death

Exosomes: biogenesis, biologic function and clinical potential

Effects of Tumor-Derived Exosome Programmed Death Ligand 1 on Tumor Immunity and Clinical Applications

Extracellular Vesicles Derived From Apoptotic Cells: An Essential Link Between Death and Regeneration

Exosomes as critical mediators of cell-to-cell communication in cancer pathogenesis and their potential clinical application

Exogenous and Endogenous Dendritic Cell-Derived Exosomes: Lessons Learned for Immunotherapy and Disease Pathogenesis

Exosomes from different cells: Characteristics, modifications, and therapeutic applications

Applications of stem cell-derived exosomes in tissue engineering and neurological diseases

Exosome nanovesicles: biomarkers and new strategies for treatment of human diseases

Mesenchymal Stem Cell-Derived Exosomes: Applications in Regenerative Medicine

Cell Death and Exosomes Regulation After Myocardial Infarction and Ischemia-Reperfusion

T cell-derived exosomes in tumor immune modulation and immunotherapy

The Exosome Journey: From Biogenesis to Regulation and Function in Cancers

Role of Stem Cell-Derived Exosomes in Cancer

The Importance of Exosomal PD-L1 in Cancer Progression and Its Potential as a Therapeutic Target

Exosomes and cancer - Diagnostic and prognostic biomarkers and therapeutic vehicle

Exosome biogenesis: machinery, regulation, and therapeutic implications in cancer

Cardiomyocyte-Derived Exosomes: Biological Functions and Potential Therapeutic Implications

Exosomes Targeted Towards Applications in Regenerative Medicine